Int’l - Boehringer Ingelheim offers combination discount for oral vaccines in USA
Published:March 6, 2006
Source :Boehringer Ingelheim Vetmedica Inc.
Boehringer Ingelheim Vetmedica, Inc., (BIVI) have announced in the US they are offering a 20 percent discount from the list price on all orders of Ingelvac® ERY-ALC for control of swine erysipelas, when shipped with an equal dose amount of Enterisol® Ileitis FF.
The special combination price for the two BIVI oral vaccines will run from March 1 until May 31, 2006. Distributors will automatically reduce the price of Ingelvac® ERY-ALC when ordered and shipped in conjunction with an equal amount of doses of Enterisol® Ileitis FF.
“The prevalence of erysipelas is higher than you might expect,” says Greg Cline, DVM in Parkville, Mo., and technical manager of BIVI “According to research, 30 to 50 percent of all clinically normal swine may harbor the organism in the tonsil at market.”
Enterisol® Ileitis FF and Ingelvac® ERY-ALC oral vaccines from BIVI have been approved for simultaneous administration by the Animal and Plant Health Inspection Service (APHIS) division of the United States Department of Agriculture (USDA). Dr. Cline recommends that swine producers work with their herd veterinarian to determine best timing of vaccination for erysipelas and ileitis.
The new label allows producers to administer oral vaccinations concurrently, while maintaining the efficacy of each vaccine. Using the vaccines concurrently allows producers to save the management time and labor expenses associated with traditional injection vaccines.
For more information about this promotion please call 800-325-9167 or click in the link provided below.
